What is Arcus Biosciences's total?

Arcus Biosciences (RCUS) reported total of $877M in Q1 2026.

How has Arcus Biosciences's total changed year-over-year?

Arcus Biosciences's total decreased by 12.7% year-over-year, from $1.01B to $877M.

What is the long-term trend for Arcus Biosciences's total?

Over 3 years (2022 to 2025), Arcus Biosciences's total has grown at a -4.1% compound annual growth rate (CAGR), from $1.15B to $1.01B.

Arcus Biosciences RCUS Total

Total at other companies

Merck & Co.MRK

——

Regeneron PharmaceuticalsREGN

——

ExelixisEXEL

——

Arcutis Biotherapeutics, Inc.ARQT

——

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's total?: Arcus Biosciences (RCUS) reported total of $877M in Q1 2026.
How has Arcus Biosciences's total changed year-over-year?: Arcus Biosciences's total decreased by 12.7% year-over-year, from $1.01B to $877M.
What is the long-term trend for Arcus Biosciences's total?: Over 3 years (2022 to 2025), Arcus Biosciences's total has grown at a -4.1% compound annual growth rate (CAGR), from $1.15B to $1.01B.